Acerus Pharmaceuticals Corporation (ASPCF)

Other OTC - Other OTC Delayed Price. Currency in USD

0.2199

0.0000

(0.00%)

At close: 09:53AM EST

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	0.2199
Open	0.2199
Bid	N/A x N/A
Ask	N/A x N/A
Day's Range	0.2199 - 0.2199
52 Week Range	0.0200 - 8.0000
Volume	500
Avg. Volume	83

Market Cap	2.046M
Beta (5Y Monthly)	1.35
PE Ratio (TTM)	N/A
EPS (TTM)	N/A
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

N/A

Subscribe to Yahoo Finance Plus to view Fair Value for ASPCF

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

ACERUS PHARMACEUTICALS CORP
Analyst Report: Microsoft CorporationMicrosoft is the world's largest independent software developer. The company was founded on the MS Windows operating system and MS Office business applications suite for PCs. As it has grown, Microsoft has expanded into enterprise software with Windows Server, SQL Server, Dynamics CRM, SharePoint, Azure, and Lync; hardware with the Xbox gaming/media platform and the Surface tablet; and online services through MSN and Bing. Microsoft acquired Skype, the internet VoIP communications service, in October 2011. More than 50% of revenue is generated outside the U.S.
Rating
Fair Value
Economic Moat
3 days agoArgus Research